Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - TAKEDA PHARMACEUTICAL CO LTD

14th Dec 2018 12:04

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 13 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 12,190,920 1.53% 14,424,825 1.82%
(2) Cash-settled derivatives:
14,132,640 1.78% 11,370,946 1.43%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,671,600 1.34% 11,091,600 1.40%
(4)
TOTAL: 36,995,160 4.66% 36,887,371 4.64%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 300 17.4566 USD
ADR Purchase 2,517 17.2800 USD
ADR Purchase 17,912 17.3032 USD
ADR Sale 300 17.4566 USD
ADR Sale 3,545 17.2800 USD
ADR Sale 17,912 17.3032 USD
Ordinary NPV Purchase 100 3,849.0000 JPY
Ordinary NPV Purchase 200 3,981.8500 JPY
Ordinary NPV Purchase 300 3,978.0000 JPY
Ordinary NPV Purchase 1,400 3,975.3928 JPY
Ordinary NPV Purchase 1,500 3,987.8000 JPY
Ordinary NPV Purchase 2,200 3,983.4545 JPY
Ordinary NPV Purchase 2,800 3,979.5000 JPY
Ordinary NPV Purchase 3,100 3,983.8419 JPY
Ordinary NPV Purchase 3,500 3,980.7714 JPY
Ordinary NPV Purchase 3,900 3,980.3333 JPY
Ordinary NPV Purchase 5,400 4,000.0000 JPY
Ordinary NPV Purchase 5,500 3,984.5000 JPY
Ordinary NPV Purchase 6,400 3,984.5625 JPY
Ordinary NPV Purchase 6,400 3,850.0000 JPY
Ordinary NPV Purchase 6,400 3,981.4218 JPY
Ordinary NPV Purchase 7,000 3,976.4228 JPY
Ordinary NPV Purchase 9,950 3,980.0000 JPY
Ordinary NPV Purchase 13,000 3,940.3538 JPY
Ordinary NPV Purchase 14,100 3,983.7375 JPY
Ordinary NPV Purchase 14,800 3,981.2770 JPY
Ordinary NPV Purchase 15,000 3,986.8000 JPY
Ordinary NPV Purchase 16,800 3,980.0238 JPY
Ordinary NPV Purchase 17,200 3,960.5755 JPY
Ordinary NPV Purchase 17,700 3,889.7231 JPY
Ordinary NPV Purchase 25,000 3,937.0400 JPY
Ordinary NPV Purchase 25,200 3,937.2063 JPY
Ordinary NPV Purchase 26,200 3,981.8893 JPY
Ordinary NPV Purchase 42,000 3,970.2190 JPY
Ordinary NPV Purchase 51,200 3,985.4121 JPY
Ordinary NPV Purchase 52,700 3,982.3074 JPY
Ordinary NPV Purchase 71,400 3,982.7997 JPY
Ordinary NPV Purchase 91,400 3,864.3501 JPY
Ordinary NPV Purchase 110,900 3,975.5589 JPY
Ordinary NPV Purchase 130,700 3,975.6170 JPY
Ordinary NPV Purchase 265,100 3,978.0920 JPY
Ordinary NPV Purchase 304,500 3,944.8834 JPY
Ordinary NPV Purchase 365,100 3,859.2577 JPY
Ordinary NPV Purchase 1,353,700 3,964.6053 JPY
Ordinary NPV Purchase 1,561,300 3,965.4805 JPY
Ordinary NPV Sale 41 3,875.5121 JPY
Ordinary NPV Sale 82 3,866.6220 JPY
Ordinary NPV Sale 100 3,981.0000 JPY
Ordinary NPV Sale 152 3,871.7960 JPY
Ordinary NPV Sale 233 3,877.1115 JPY
Ordinary NPV Sale 394 3,876.4873 JPY
Ordinary NPV Sale 400 3,984.0000 JPY
Ordinary NPV Sale 400 3,983.0000 JPY
Ordinary NPV Sale 1,078 3,876.5839 JPY
Ordinary NPV Sale 1,400 3,975.3928 JPY
Ordinary NPV Sale 1,500 3,987.8000 JPY
Ordinary NPV Sale 1,800 3,980.0000 JPY
Ordinary NPV Sale 2,800 3,979.5000 JPY
Ordinary NPV Sale 3,100 3,983.8419 JPY
Ordinary NPV Sale 6,800 3,976.7058 JPY
Ordinary NPV Sale 7,000 3,976.4228 JPY
Ordinary NPV Sale 16,700 3,980.0179 JPY
Ordinary NPV Sale 17,600 3,889.9090 JPY
Ordinary NPV Sale 20,500 3,982.1473 JPY
Ordinary NPV Sale 26,300 3,951.1520 JPY
Ordinary NPV Sale 42,000 3,970.2190 JPY
Ordinary NPV Sale 51,200 3,984.5546 JPY
Ordinary NPV Sale 67,600 3,976.1982 JPY
Ordinary NPV Sale 96,000 3,925.8333 JPY
Ordinary NPV Sale 98,720 3,973.2740 JPY
Ordinary NPV Sale 110,900 3,975.5589 JPY
Ordinary NPV Sale 130,700 3,969.2486 JPY
Ordinary NPV Sale 132,600 3,975.2398 JPY
Ordinary NPV Sale 144,900 3,976.4102 JPY
Ordinary NPV Sale 876,000 3,943.9121 JPY
Ordinary NPV Sale 1,356,300 3,964.6348 JPY
Ordinary NPV Sale 1,493,700 3,964.9955 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 11 3,866.7293 JPY
Ordinary NPV SWAP Long 30 3,878.7284 JPY
Ordinary NPV SWAP Long 62 3,870.6129 JPY
Ordinary NPV SWAP Long 82 3,866.6132 JPY
Ordinary NPV SWAP Long 82 3,873.8000 JPY
Ordinary NPV SWAP Long 90 3,872.6127 JPY
Ordinary NPV SWAP Long 97 3,887.6112 JPY
Ordinary NPV SWAP Long 151 3,878.9120 JPY
Ordinary NPV SWAP Long 212 3,874.9031 JPY
Ordinary NPV SWAP Long 297 3,872.8540 JPY
Ordinary NPV SWAP Long 866 3,876.9948 JPY
Ordinary NPV SWAP Long 1,600 3,980.0000 JPY
Ordinary NPV SWAP Long 1,700 3,850.4152 JPY
Ordinary NPV SWAP Long 45,220 3,974.2114 JPY
Ordinary NPV SWAP Long 53,500 3,972.4816 JPY
Ordinary NPV CFD Long 260,000 3,920.9220 JPY
Ordinary NPV SWAP Short 300 3,982.6666 JPY
Ordinary NPV SWAP Short 1,200 3,999.1791 JPY
Ordinary NPV CFD Short 9,950 3,980.0000 JPY
Ordinary NPV CFD Short 17,400 3,850.3850 JPY
Ordinary NPV SWAP Expires 13/12/2018 Short 339,100 4,141.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 14 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -150,000 3889.0000 American 11 Jun 2021
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Call Options Written -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Purchased -10,000,000 4206.0397 European 7 Jan 2019
Ordinary NPV Put Options Written 10,000,000 4206.0397 European 7 Jan 2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181214005193/en/

Copyright Business Wire 2018


Related Shares:

Barclays
FTSE 100 Latest
Value9,023.81
Change10.82